Member Info for EmeraldCarrots

"I contacted NICE who confirmed the 15th Aug date. Should see a steady sp rise then over next few weeks." (Sp at the time 1.40p) 18/07/25".

==

Was that Mr Hendrix? What's the betting that is wrong?

Kaeren.

Thinking about it, how long untill all the Scottish hospitals have the MT-RNR1? We don't know. However we know they start in October. It is a phased installation. Well, they do not have the staff to do them all at once anyway, let's face it. The value is around £800,000. So if it's over 6 months that is £133,333 a month. They will have the income from the 14 ish England sites and the one corinary machine job which is £120,000. So by April they might have 15 (Scottish) + 15(English) + 7 (international) = 37 hospitals using 1 machine or other, ****assuming no more orders AT ALL****. There is no reason to think they won't get more orders in the coming months remember. It's a close call.

All IMHO.

Clearly the man is a genius. A few years back I noted he posted "do the reverse of what I post" and you will be rich, probably.

Will one of these bid?

https://www.healthcaretalentlink.com/blog/top-10-medical-equipment-distributors-and-suppliers-in-the-usa/

That would be interesting.

Crazy! Or not?

The most negative posts of anyone. What is the reason please?

Now users but cagey on detail. Even if it's one hospital per country and one machine it makes a difference to a small Plc. Any one of those could see an upsurge in orders. In some countries all cover might be private. In which case a chain of private hospitals might want the publicity of saving babies from being rendered deaf to get an advantage over competitors?

From todays RNS:-

"It is important that we focus commercial efforts outside of the challenging market presented by the UK NHS, and I am pleased that our year-on-year revenue growth evidences product-market fit, both in our domestic market and international territories where we are seeing initial operational and commercial traction in European countries adopting, such as Italy, Netherlands, and Middle East countries including UAE, Bahrain, Kuwait, Saudi Arabia and Qatar, and I look forward to further growth in these and other regions as we progress."

My word. Maybe an extablished medical machine supplier can't believe their eyes and are going to bid? If they are established in the European Union already then great! If they are also established as a medical supplier in the USA then they must think the current sp is a gift from God.

Total madness?

Guy_incognito

"Are you on a wind up"

=======

Bid went from 0.9 to 0.95 so that seems to be up. What else do you call it? LOL!

Tick up.

Roll out I would have thought. As I understand it this is not for evaluating the MT-RNR1 machine. Its for the installation and use as the Scottish NHS do not think it needs further testing like NHS England and Wales. So far less "paperwork" in getting each result double checked at a lab (IMHO a total waste of time and money). Genedrive will want the 15 or so hospitals up and running asap. Starts October.

JimiHendrix.

Is this something you made up and posted on here? If not where is the proof such a thing will happen............... one day.

Rud20.

"Potentially the hold off on another raise could be linked to the potentially imminent NHSE implementation guidance. If they know this to be positive, with the likely annual revenue of £8m then once this is confirmed, the could easily obtain a commercial loan (non dilutive) based on guaranteed revenue from NHSE. Ita a timing this of course, the longer NHSE guidance takes the greater likelihood of the old style dilution. So hard to know, but just my take on it."

=======================

The implementation guidance is weeks overdue. You may be right.

I wonder if Hospitals insurance fees could be reduced by installing Genedrive machines? Also massive cost savings if they do. If a baby does NOT go deaf, if a stroke patient does NOT have a second stroke. Tens if not hundreds of millions of £ saved.

Or more of the eight ** COUNTRIES ** would make a massive difference. Just off the top of my head they have orders for:-

1. Scotland, about 15 hospitals (Scottish rollout, MT-RNR1 machine).

2. England/wales 5 more to bring it up to the 14 (MT-RNR1 machine).

3. England 1 for corinary dept evaluation (CYP2C19-ID machine).

So they have ***21*** installations to do and that ***excludes ANY*** from the other 7 Countries in the EU. and Middle East!

Not so bad, is it?

Tick up again

Be eligible to apply for shares at the placing price.

At 1p a share (now) the market cap is just £6m. Is that right for a Company who has the UK's NHS as a regular client, and is making inroads into 7 other Countries in the EU and Middle East? Placse 'yer bets!

The UK are using one or both machines. So 8 Countries are now clients of Genedrive. Is that not significant?